WEDBUSH SECURITIES INC - CYCLACEL PHARMACEUTICALS INC ownership

CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 17 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$12,000
-57.1%
22,400
+6.7%
0.00%
-75.0%
Q1 2018$28,000
-44.0%
21,000
-23.4%
0.00%
-33.3%
Q3 2017$50,000
-3.8%
27,400
+97.1%
0.01%
-14.3%
Q2 2017$52,00013,9000.01%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 559,900$2,111,0000.75%
WEDBUSH SECURITIES INC 13,900$52,0000.01%
MinichMacGregor Wealth Management, LLC 800$3,0000.00%
UBS Group AG 180$1,0000.00%
D'Orazio & Associates, Inc. 100$00.00%
DIMENSIONAL FUND ADVISORS LP 30,913$117,0000.00%
Parallel Advisors, LLC 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 21,692$82,0000.00%
DEUTSCHE BANK AG\ 2,403$9,0000.00%
PANAGORA ASSET MANAGEMENT INC 10,346$39,0000.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders